Tumor immunology CRISPR screening: present, past, and future

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Immunotherapy has revolutionized cancer treatment by harnessing the adaptive immune system.
• Understanding immune recognition is key to developing next-generation cancer therapies.

Purpose of the Study:

• To review the application of clustered regularly interspaced short palindromic repeats (CRISPR) technology in tumor immunology.
• To outline the essential components for conducting immune-specific CRISPR screens.
• To identify future research directions in CRISPR-based cancer immunotherapy.

Main Methods:

• Literature review of CRISPR screens in the context of tumor immunology.
• Analysis of multiomics modalities accelerating discovery.
• Identification of key components for immune-specific CRISPR screening.

Main Results:

• CRISPR technology significantly accelerates the discovery process in tumor immunology.
• Multiomics advancements complement CRISPR screens for deeper insights.
• Essential components for immune-specific CRISPR screens have been identified.

Conclusions:

• CRISPR screens are a powerful tool for advancing tumor immunology.
• Future research should focus on refining immune-specific CRISPR screening strategies.
• This approach holds promise for developing novel and effective cancer immunotherapies.